Company intelligence / Profile preview

Mode Sensors

Trondheim, Trøndelag, Norwaymodesensors.com ↗

Ownership: Private
Employees: ~12
Development stage: Commercial

Overview

Mode Sensors has developed the Re:Balans® wearable, which provides continuous, real-time hydration monitoring. The device has been tested in over seven completed clinical studies and is currently undergoing further clinical trials. It is not yet CE certified as a medical device but has produced over 1000 devices for clinical testing and received significant investment (>10M USD). Early results indicate strong potential for improving fluid management in at-risk patient populations.

Therapeutic areas: Metabolic DisordersNephrology
Modalities: DeviceWearable biosensor technology
Industry: Physiological Monitoring

Partnerships

Lockheed Martin

Beyond the preview

Go deeper on Mode Sensors.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mode Sensors.

Explore the full profile